B.Riley Financial Remains a Buy on Intercept Pharma (ICPT)

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Intercept Pharma (ICPT – Research Report), wi...

Related Keywords

New York ,United States ,Piper Sandler ,Marke Pruzanski ,Mayank Mamtani ,Intercept Pharmaceuticals Inc , ,Intercept Pharma ,Research Report ,Moderate Buy ,Roberto Pellicciari ,